|
Volumn 26, Issue 5, 2009, Pages 585-599
|
Uremic pruritus: an unresolved challenge;Lettera del Presidente.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID;
AMINE;
ANALGESIC AGENT;
ANTIPRURITIC AGENT;
CAPSAICIN;
CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;
EMOLLIENT AGENT;
GABAPENTIN;
MORPHINAN DERIVATIVE;
NALFURAFINE;
SPIRO COMPOUND;
DRUG COMBINATION;
EVIDENCE BASED MEDICINE;
HUMAN;
INTRADERMAL DRUG ADMINISTRATION;
ITALY;
METHODOLOGY;
PATHOPHYSIOLOGY;
PHOTOTHERAPY;
PROGNOSIS;
PRURITUS;
QUALITY OF LIFE;
RENAL REPLACEMENT THERAPY;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
UREMIA;
ADMINISTRATION, CUTANEOUS;
AMINES;
ANALGESICS;
ANTIPRURITICS;
CAPSAICIN;
CYCLOHEXANECARBOXYLIC ACIDS;
DRUG THERAPY, COMBINATION;
EMOLLIENTS;
EVIDENCE-BASED MEDICINE;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
ITALY;
MORPHINANS;
PROGNOSIS;
PRURITUS;
QUALITY OF LIFE;
RENAL DIALYSIS;
RISK FACTORS;
SPIRO COMPOUNDS;
TREATMENT OUTCOME;
ULTRAVIOLET THERAPY;
UREMIA;
|
EID: 77955479276
PISSN: 03935590
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (133)
|